BSPM - Biostar Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/201412/31/2013
Total Revenue2,384.49227,129.60961,416.58752,729.054
Cost of Revenue1,469.31816,025.54431,140.22527,046.216
Gross Profit915.17411,104.06530,276.36225,682.838
Operating Expenses
Research Development----
Selling General and Administrative----
Non Recurring----
Others----
Total Operating Expenses5,948.75438,001.26360,111.52551,980.742
Operating Income or Loss-3,564.262-10,871.6541,305.062748.312
Income from Continuing Operations
Total Other Income/Expenses Net----
Earnings Before Interest and Taxes-3,564.262-10,871.6541,305.062748.312
Interest Expense-206.195-283.596-154.547-367.493
Income Before Tax----
Income Tax Expense2,653.0541,319.846-3,313.5811,846.98
Minority Interest----
Net Income From Continuing Ops----
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-5,698.385-25,112.5624,848.212809.046
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares----